Study population |
1. Was a method of randomisation performed? |
2. Was the allocation of treatment concealed? |
3. Were the groups similar at baseline regarding the most important prognostic indicators (age, gender, disease duration, disease severity)? | |
4. Were both inclusion and exclusion criteria specified? | |
Blinding
-
Was the outcome assessor blinded? -
Was the care provider blinded? -
Was the patient blinded?
| |
Analysis
-
Were point estimates and measures of variability presented for the primary outcomes? -
Did the analysis include an intention-to-treat analysis? -
Was the withdrawal/drop-out rate at <20% and equally distributed?
| |